Finance

Lists
Why is ZURA up 3,75%?
Dive Deeper
ZURA:NASDAQ
Zura Bio Ltd
4,15 $
+3,75%
(+0,15) 1D
30 սեպ, 12:51:46 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZURA...
Open
4,04 $
High
4,17 $
Low
3,98 $
Mkt. cap
397,69 մլն
Avg. vol.
1,80 մլն
Volume
1,59 մլն
52-wk high
7,44 $
52-wk low
3,15 $
EPS
-1,12 $
Beta
-0,01
Shares outstanding
95,83 մլն
No. of employees
40
Open
4,04 $
High
4,17 $
Low
3,98 $
Mkt. cap
397,69 մլն
Avg. vol.
1,80 մլն
Volume
1,59 մլն
52-wk high
7,44 $
52-wk low
3,15 $
EPS
-1,12 $
Beta
-0,01
Shares outstanding
95,83 մլն
No. of employees
40
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
12 ժամ առաջ
Zura Bio stock enters a key trial data phase
About Zura Bio Ltd
CEO-
Employees40
Founded2022
Headquarters-
Sector-
Websitezurabio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ZURA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ZURA in the last 3 months.
Highest
Current 4,15 $
26,00 $ (+526,51%)
Average
22,67 $ (+446,27%)
Lowest
20,00 $ (+381,93%)
Analyst
Recommendation
Action
Price target
Projected
Date
Martin Fan
Wedbush
Buy
Maintained
22,00 $
+430,1%
08/12/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
20,00 $
+381,9%
08/11/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
08/11/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
26,00 $
+526,5%
07/17/2026
Justin Kim
Oppenheimer
Buy
Reiterated
16,00 $
+285,5%
06/08/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
11,00 $
+165,1%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11,95 մլն
10,96 մլն
14,75 մլն
20,71 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,57 մլն
7,46 մլն
10,75 մլն
8,62 մլն
Operating expense
19,52 մլն
18,41 մլն
25,50 մլն
29,32 մլն
Total operating expenses
19,52 մլն
18,41 մլն
25,50 մլն
29,32 մլն
Operating income
-19,52 մլն
-18,41 մլն
-25,50 մլն
-29,32 մլն
Other non operating income
-47,00 հզր
-40,00 հզր
-43,00 հզր
1,02 մլն
EBT including unusual items
-18,04 մլն
-17,18 մլն
-24,22 մլն
-26,38 մլն
EBT excluding unusual items
-18,04 մլն
-17,18 մլն
-24,22 մլն
-26,38 մլն
Income tax expense
-
-
-
-81,00 հզր
Effective tax rate
-
-
-
0,31%
Other operating expenses
-
-
-
-
Net income
-18,04 մլն
-17,18 մլն
-24,22 մլն
-26,30 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-0,49
-0,22
-0,21
Interest and investment income
1,53 մլն
1,28 մլն
1,32 մլն
1,92 մլն
Interest expense
-
-
-
-
Net interest expenses
1,53 մլն
1,28 մլն
1,32 մլն
1,92 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-19,50 մլն
-18,40 մլն
-25,48 մլն
-29,30 մլն
Gain or loss from assets sale
-
-
3,00 հզր
2,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps